Nuvig Therapeutics
Redwood City
About Nuvig Therapeutics
Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $208.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2024)
- Website: nuvigtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nuvig-therapeutics-103744 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.